AbbVie

AbbVie (ABBV) is a research-driven biopharmaceutical company with blockbuster franchises in immunology (Skyrizi, Rinvoq), oncology, aesthetics (Botox), and neuroscience. After navigating the Humira biosimilar patent cliff, AbbVie has demonstrated strong revenue resilience through its diversified portfolio and robust pipeline. The stock is a favorite among dividend investors thanks to its Dividend Aristocrat status and generous payout yield.

Threads